October 23, 2015
Chugai Pharmaceutical said on October 22 that it will invest 37.2 billion yen to build a new manufacturing plant for antibody active pharmaceutical ingredients (APIs) in Tokyo, which is scheduled to go on line in June 2019. The move aims...read more